✦ LIBER ✦

Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy

✍ Scribed by Arkan S. Sayed-Noor; Göran O. Sjödén

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 291 KB
Volume: 467
Category: Article
ISSN: 0009-921X
DOI: 10.1007/s11999-009-0725-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Case Reports: Subtrochanteric Femoral St

Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy

✍ Katerina Cermak; Felix Shumelinsky; Jean Alexiou; Michael J. Gebhart 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 304 KB

Is Surgery Necessary for Femoral Insuffi

Is Surgery Necessary for Femoral Insufficiency Fractures after Long-term Bisphosphonate Therapy?

✍ Yong-Chan Ha; Myung-Rae Cho; Ki Hong Park; Shin-Yoon Kim; Kyung-Hoi Koo 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 243 KB

Bilateral subchondral insufficiency frac

Bilateral subchondral insufficiency fracture of the femoral head after renal transplantation: A case report

✍ Satoshi Ikemura; Takuaki Yamamoto; Yasuharu Nakashima; Toshihide Shuto; Seiya Ji 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Hip fracture after radiofrequency ablati

Hip fracture after radiofrequency ablation therapy for bone tumors: two case reports

✍ Edwin F. Dierselhuis; Paul C. Jutte; Pepijn J. M. van der Eerden; Albert J. H. S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 293 KB

Remission of acromegaly following long-t

Remission of acromegaly following long-term therapy with cabergoline: report of two cases

✍ Johan A. Verhelst; Pascale J. Abrams; Roger Abs 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 155 KB

Long-term remission in hodgkin's disease

Long-term remission in hodgkin's disease after nitrogen mustard therapy. Report of a Case

✍ Joseph M. Kiely; Edgar G. Harrison JR. 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 762 KB

A patient with Hodgkin's disease (Stage IIB) was given nitrogen mustard shortly after diagnosis and has survived, without recurrence, for more than 5 years. HFhfOTHERAPY FOR CANCER IS OFTEN OF C palliative benefit but is only rarely curative. Single-agent chemotherapy4, 5 , 9 has achieved cure rate